These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35470796)

  • 1. SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.
    Harris JR; Owusu D; O'Laughlin K; Cohen AL; Ben Hamida A; Patel JC; Freeman MM; Nsibambi T; Nieves R; Marston BJ; Wasike S; Galbraith JS; Boore AL; Nelson LJ; Guagliardo SAJ; Klena JD; Patel K; Ma M
    Emerg Infect Dis; 2022 Jun; 28(6):1279-1280. PubMed ID: 35470796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda.
    Mugisha J; Mpairwe B; Newton R; Cotten M; Phan MVT
    Emerg Infect Dis; 2023 Jan; 29(1):224-226. PubMed ID: 36529453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.
    Yi S; Choe YJ; Kim J; Kim YY; Kim RK; Jang EJ; Lim DS; Byeon HR; Lee S; Park E; Kim SJ; Park YJ
    Emerg Infect Dis; 2022 Mar; 28(3):753-756. PubMed ID: 35202529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.
    Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W
    Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Genomic Variation Associated With Breakthrough Infection in Northern California: A Retrospective Cohort Study.
    Skarbinski J; Nugent JR; Wood MS; Liu L; Bullick T; Schapiro JM; Arunleung P; Morales C; Amsden LB; Hsiao CA; Wadford DA; Chai SJ; Reingold A; Wyman SK
    J Infect Dis; 2023 Oct; 228(7):878-888. PubMed ID: 37195913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
    Laing ED; Weiss CD; Samuels EC; Coggins SA; Wang W; Wang R; Vassell R; Sterling SL; Tso MS; Conner T; Goguet E; Moser M; Jackson-Thompson BM; Illinik L; Davies J; Ortega O; Parmelee E; Hollis-Perry M; Maiolatesi SE; Wang G; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Lindrose AR; Duplessis CA; Tribble DR; Malloy AMW; Burgess TH; Pollett SD; Olsen CH; Broder CC; Mitre E
    Emerg Infect Dis; 2022 Apr; 28(4):828-832. PubMed ID: 35203111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and Correlates of Breakthrough Infections With SARS-CoV-2.
    Yamal JM; Appana S; Wang M; Leon-Novelo L; Bakota E; Ye Y; Sharma S; Morrison AC; Marko D; Linder SH; Rector A; Jetelina KK; Boerwinkle E; de Oliveira Otto M
    Front Public Health; 2022; 10():856532. PubMed ID: 35619825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.
    Glatman-Freedman A; Hershkovitz Y; Kaufman Z; Dichtiar R; Keinan-Boker L; Bromberg M
    Emerg Infect Dis; 2021 Nov; 27(11):2919-2922. PubMed ID: 34570694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants.
    Kislaya I; Rodrigues EF; Borges V; Gomes JP; Sousa C; Almeida JP; Peralta-Santos A; Nunes B;
    Emerg Infect Dis; 2022 Feb; 28(2):331-337. PubMed ID: 34876242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Replacement of SARS-CoV-2 Variants by Delta and Subsequent Arrival of Omicron, Uganda, 2021.
    Bbosa N; Ssemwanga D; Namagembe H; Kiiza R; Kiconco J; Kayiwa J; Lutalo T; Lutwama J; Ssekagiri A; Ssewanyana I; Nabadda S; Kyobe-Bbosa H; Giandhari J; Pillay S; Ramphal U; Ramphal Y; Naidoo Y; Tshiabuila D; Tegally H; San EJ; Wilkinson E; de Oliveira T; Kaleebu P
    Emerg Infect Dis; 2022 May; 28(5):1021-1025. PubMed ID: 35320700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
    Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
    Teran RA; Walblay KA; Shane EL; Xydis S; Gretsch S; Gagner A; Samala U; Choi H; Zelinski C; Black SR
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):632-638. PubMed ID: 33914721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) outbreaks in nursing homes involving residents who had completed a primary coronavirus disease 2019 (COVID-19) vaccine series-13 US jurisdictions, July-November 2021.
    Wilson WW; Keaton AA; Ochoa LG; Hatfield KM; Gable P; Walblay KA; Teran RA; Shea M; Khan U; Stringer G; Colletti JG; Grogan EM; Calabrese C; Hennenfent A; Perlmutter R; Janiszewski KA; Kamal-Ahmed I; Strand K; Berns E; MacFarquhar J; Linder M; Tran DJ; Kopp P; Walker RM; Ess R; Read JS; Yingst C; Baggs J; Jernigan JA; Kallen A; Hunter JC;
    Infect Control Hosp Epidemiol; 2023 Jun; 44(6):1005-1009. PubMed ID: 36645205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
    Servellita V; Morris MK; Sotomayor-Gonzalez A; Gliwa AS; Torres E; Brazer N; Zhou A; Hernandez KT; Sankaran M; Wang B; Wong D; Wang C; Zhang Y; Reyes KR; Glasner D; Deng X; Streithorst J; Miller S; Frias E; Rodgers M; Cloherty G; Hackett J; Hanson C; Wadford D; Philip S; Topper S; Sachdev D; Chiu CY
    Nat Microbiol; 2022 Feb; 7(2):277-288. PubMed ID: 35013591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward.
    Wi YM; Kim SH; Peck KR
    J Korean Med Sci; 2022 Jan; 37(4):e28. PubMed ID: 35075827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State.
    McEwen AE; Cohen S; Bryson-Cahn C; Liu C; Pergam SA; Lynch J; Schippers A; Strand K; Whimbey E; Mani NS; Zelikoff AJ; Makarewicz VA; Brown ER; Bakhash SAM; Baker NR; Castor J; Livingston RJ; Huang ML; Jerome KR; Greninger AL; Roychoudhury P
    Clin Infect Dis; 2022 Mar; 74(6):1089-1092. PubMed ID: 34166484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.